Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $416000.0.

  • Camp4 Therapeutics' Depreciation & Amortization (CF) fell 47.85% to $416000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 163.46%. This contributed to the annual value of $1.7 million for FY2024, which is 107.27% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $416000.0 for Q3 2025, which was down 47.85% from $430000.0 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Depreciation & Amortization (CF) registered a high of $436000.0 during Q1 2024, and its lowest value of $416000.0 during Q3 2025.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $422500.0 (2024), whereas its average is $424750.0.
  • Per our database at Business Quant, Camp4 Therapeutics' Depreciation & Amortization (CF) tumbled by 390.8% in 2024 and then skyrocketed by 141.51% in 2025.
  • Camp4 Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $435000.0 in 2023, then decreased by 3.91% to $418000.0 in 2024, then decreased by 0.48% to $416000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $416000.0 for Q3 2025, versus $430000.0 for Q2 2025 and $421000.0 for Q1 2025.